Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France

---

XELJANZ is a medicine that contains the active substance tofacitinib. Tofacitinib is a small molecule that blocks the activity of a protein inside human cells which can cause inflammation. XELJANZ can be used for moderate or severe active rheumatoid arthritis, for active psoriatic arthritis or for moderate or severely active ulcerative colitis – in each case usually when other widely used treatments have not worked well enough or are not suitable.

---

Size: 6000px × 4000px
Location: Paris, France
Photo credit: © Jane Ali / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 11mg, arthritis, background, blister, box, citrate, colitis, daily, day, drug, effects, france, french, health, immunosuppresant, immunosuppressive, inhibitor, jak, janus, jour, kinase, medication, medicine, molecule, oral, pack, packaging, packet, par, pfizer, pills, plain, prescribed, prise, psoriatic, release, rheumatoid, sharp, side, silver, simple, slow, small, sterile, sustained, tablet, tablets, tofacitinib, treatment, ulcerative, une, xeljanz